https://www.marketscreener.com/quote/stock/BEIGENE-LTD-26123632/news/BeiGene-Presents-Data-at-ESMO-Virtual-Congress-2020-on-Phase-3-Trial-of-Tislelizumab-in-First-Line-31317122/?utm_source=telegram&utm_medium=social&utm_campaign=share